Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (411-420 of 1,289) with videos related to

Pageof 129
Sort By:
Leukemia|May 21, 2016
Decrease in total protein level of Bruton's tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytesF Cervantes-Gomez, V Kumar Patel, P Bose, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 1, 1990
The effects of swabbing the skin on apparent blood ethanol concentrationG J Peek, A Marsh, J Keating, et al.
Leukemia & Lymphoma|June 20, 2015
Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cellsFabiola Cervantes-Gomez, Bethany Lavergne, Michael J Keating, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 1, 2007
Somatostatin decreases voltage-gated Ca2+ currents in GH3 cells through activation of somatostatin receptor 2Seung-Kwon Yang, Helena C Parkington, Jacques Epelbaum, et al.
Journal of Biomedical Materials Research|January 15, 2000
Mechanical environment affects allograft incorporationJ Benevenia, M Zimmerman, J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemiaV Gandhi, E Estey, M Du, et al.
Endocrine|January 3, 2006
Ghrelin reduces voltage-gated potassium currents in GH3 cells via cyclic GMP pathwaysXue Feng Han, Yun Long Zhu, Maria Hernandez, et al.
Leukemia Research|August 4, 2009
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 YearsStefan Faderl, William Wierda, Susan O'Brien, et al.
Leukemia|November 1, 1992
New drugs in the treatment of chronic lymphocytic leukemiaM J Keating, S O'Brien, L Robertson, et al.
Cancer Research|November 1, 1990
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemiaR Grunewald, H Kantarjian, M J Keating, et al.
Pageof 129

Showing results (411-420 of 1,289) with videos related to

Sort By:
Pageof 129
Leukemia|May 21, 2016
Decrease in total protein level of Bruton's tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytesF Cervantes-Gomez, V Kumar Patel, P Bose, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 1, 1990
The effects of swabbing the skin on apparent blood ethanol concentrationG J Peek, A Marsh, J Keating, et al.
Leukemia & Lymphoma|June 20, 2015
Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cellsFabiola Cervantes-Gomez, Bethany Lavergne, Michael J Keating, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 1, 2007
Somatostatin decreases voltage-gated Ca2+ currents in GH3 cells through activation of somatostatin receptor 2Seung-Kwon Yang, Helena C Parkington, Jacques Epelbaum, et al.
Journal of Biomedical Materials Research|January 15, 2000
Mechanical environment affects allograft incorporationJ Benevenia, M Zimmerman, J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemiaV Gandhi, E Estey, M Du, et al.
Endocrine|January 3, 2006
Ghrelin reduces voltage-gated potassium currents in GH3 cells via cyclic GMP pathwaysXue Feng Han, Yun Long Zhu, Maria Hernandez, et al.
Leukemia Research|August 4, 2009
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 YearsStefan Faderl, William Wierda, Susan O'Brien, et al.
Leukemia|November 1, 1992
New drugs in the treatment of chronic lymphocytic leukemiaM J Keating, S O'Brien, L Robertson, et al.
Cancer Research|November 1, 1990
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemiaR Grunewald, H Kantarjian, M J Keating, et al.
Pageof 129